Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
16.04.2025 14:11:41
|
Abbott Laboratories Q1 Profit Increases, Beats Estimates
(RTTNews) - Abbott Laboratories (ABT) announced earnings for its first quarter that increased from last year and beat the Street estimates.
The company's earnings totaled $1.325 billion, or $0.76 per share. This compares with $1.225 billion, or $0.70 per share, last year.
Excluding items, Abbott Laboratories reported adjusted earnings of $1.919 billion or $1.09 per share for the period.
Analysts on average had expected the company to earn $1.07 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 4.0% to $10.358 billion from $9.964 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings: $1.325 Bln. vs. $1.225 Bln. last year. -EPS: $0.76 vs. $0.70 last year. -Revenue: $10.358 Bln vs. $9.964 Bln last year.
-Guidance: Next quarter EPS guidance: $1.23 - $1.27 Full year EPS guidance: $5.05 - $5.25

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 115,50 | -0,41% |
|